Cargando…

Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis

Cancer cells are known to undergo metabolic adaptation to cater to their enhanced energy demand. Nicotinamide adenine dinucleotide (NAD) is an essential metabolite regulating many cellular processes within the cell. The enzymes required for NAD synthesis, starting from the base precursor - tryptopha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chedere, Adithya, Mishra, Madhulika, Kulkarni, Omkar, Sriraman, Shrisruti, Chandra, Nagasuma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565660/ https://www.ncbi.nlm.nih.gov/pubmed/36249025 http://dx.doi.org/10.3389/fonc.2022.954512

Ejemplares similares

EpiTracer - an algorithm for identifying epicenters in condition-specific biological networks
por: Sambaturu, Narmada, et al.
Publicado: (2016)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

GPBAR1 is associated with asynchronous bone metastasis and poor prognosis of hepatocellular carcinoma
por: Chen, Nan, et al.
Publicado: (2023)

Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
por: Mah, Way-Champ, et al.
Publicado: (2014)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

A Greedy Algorithm-Based Stem Cell LncRNA Signature Identifies a Novel Subgroup of Lung Adenocarcinoma Patients With Poor Prognosis
por: Khadirnaikar, Seema, et al.
Publicado: (2020)

Correction: Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
por: Mah, Way-Champ, et al.
Publicado: (2016)

CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2019)

High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2022)

NAD Metabolism in Cancer Therapeutics
por: Yaku, Keisuke, et al.
Publicado: (2018)

Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2023)

Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ji, Jia, et al.
Publicado: (2018)

Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma
por: Zhang, Youfu, et al.
Publicado: (2022)

Inhibition of protein translation under matrix-deprivation stress in breast cancer cells
por: Warrier, Shweta, et al.
Publicado: (2023)

High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma
por: Chen, Xi, et al.
Publicado: (2022)

Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
por: Han, Fang, et al.
Publicado: (2023)

“NAD-capQ” detection and quantitation of NAD caps
por: Grudzien-Nogalska, Ewa, et al.
Publicado: (2018)

NAD+ biosynthesis metabolism predicts prognosis and indicates immune microenvironment for breast cancer
por: Yang, Yuting, et al.
Publicado: (2023)

Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma
por: Luo, Qiong, et al.
Publicado: (2020)

Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach
por: Fei, Xiaobin, et al.
Publicado: (2022)

Metabolism-related signatures is correlated with poor prognosis and immune infiltration in hepatocellular carcinoma via multi-omics analysis and basic experiments
por: Shen, Jiapei, et al.
Publicado: (2023)

Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma
por: Ma, Wanshan, et al.
Publicado: (2022)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

Case report: Paratesticular dedifferentiated liposarcoma with poor prognosis
por: Suto, Hirotaka, et al.
Publicado: (2022)

Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro
por: Li, Shanbao, et al.
Publicado: (2023)

Multi-Stability and Consequent Phenotypic Plasticity in AMPK-Akt Double Negative Feedback Loop in Cancer Cells
por: Chedere, Adithya, et al.
Publicado: (2021)

High Pretreatment LDH Predicts Poor Prognosis in Hypopharyngeal Cancer
por: Wu, Jialing, et al.
Publicado: (2021)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

PSMC2 Regulates Cell Cycle Progression Through the p21/Cyclin D1 Pathway and Predicts a Poor Prognosis in Human Hepatocellular Carcinoma
por: Liu, Yiwei, et al.
Publicado: (2021)

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients
por: Jia, Bin, et al.
Publicado: (2023)

NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer
por: Phippen, Neil T., et al.
Publicado: (2016)

Acidic Urine Is Associated With Poor Prognosis of Upper Tract Urothelial Carcinoma
por: Han, Jang Hee, et al.
Publicado: (2022)

Breakouts—A Radiological Sign of Poor Prognosis in Patients With Brain Metastases
por: Blazquez, Raquel, et al.
Publicado: (2022)

TOP2A correlates with poor prognosis and affects radioresistance of medulloblastoma
por: Zhang, Yufeng, et al.
Publicado: (2022)

Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Ziying, et al.
Publicado: (2021)

Early T Stage Is Associated With Poor Prognosis in Patients With Metastatic Liver Colorectal Cancer
por: Wu, Lunpo, et al.
Publicado: (2020)

SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis
por: Liu, Ruoyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m7hete4di2q2j57s0gq6bbl4p3